Literature DB >> 3319811

Augmentation of chemically induced pancreatic and bronchial cancers by epidermal growth factor.

R A Malt1, J F Chester, H A Gaissert, J S Ross.   

Abstract

The incidence of Syrian golden hamsters with pancreatic cancer induced by subcutaneous injections of N-nitroso-bis(2-oxopropyl)amine for 19 weeks (each 10 mg/kg) increased from 44% to 75% (p=0.016) when epidermal growth factor was also administered from week 5 through week 8 (5 mug energy three days for injections). Epidermal growth factor increased pancreatic weight and body weight. The incidence of animals with bronchial cancer doubled. Epidermal growth factor could be a cocarcinogen as a result of its mitogenic activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319811      PMCID: PMC1434533          DOI: 10.1136/gut.28.suppl.249

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Pancreatic cancer in the Syrian hamster induced by N-nitrosobis(2-oxopropyl)-amine: cocarcinogenic effect of epidermal growth factor.

Authors:  J F Chester; H A Gaissert; J S Ross; R A Malt
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

2.  Epidermal growth factor enhancement of skin tumor induction in mice.

Authors:  S P Rose; R Stahn; D S Passovoy; H Herschman
Journal:  Experientia       Date:  1976

3.  Contrasting effects of subtotal enteric bypass, enterectomy, and colectomy on azoxymethane-induced intestinal carcinogenesis.

Authors:  R C Williamson; F L Bauer; O T Terpstra; J S Ross; R A Malt
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

4.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

5.  Metabolism of pancreatic carcinogens N-nitroso-2,6-dimethylmorpholine and N-nitrosobis(2-oxopropyl)amine by microsomes and cytosol of hamster pancreas and liver.

Authors:  D M Kokkinakis; D G Scarpelli; M S Rao; P F Hollenberg
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

6.  Development of a transplantable model of pancreatic duct adenocarcinoma.

Authors:  C M Townsend; R B Franklin; F B Gelder; E Glass; J C Thompson
Journal:  Surgery       Date:  1982-07       Impact factor: 3.982

7.  Adaptation to jejunoileal bypass promotes experimental colorectal carcinogenesis.

Authors:  J B Bristol; M Wells; R C Williamson
Journal:  Br J Surg       Date:  1984-02       Impact factor: 6.939

8.  Augmentation of carcinogenesis by N-nitrosobis(2-oxopropyl)amine administered during S phase of the cell cycle in regenerating hamster pancreas.

Authors:  D G Scarpelli; M S Rao; V Subbarao
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

9.  Variations in mortality by weight among 750,000 men and women.

Authors:  E A Lew; L Garfinkel
Journal:  J Chronic Dis       Date:  1979

10.  Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease.

Authors:  P M Pour; R G Runge; D Birt; R Gingell; T Lawson; D Nagel; L Wallcave; S Z Salmasi
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

View more
  4 in total

1.  Transforming growth factor alpha is trophic to pancreatic cancer in vivo.

Authors:  N Davies; P Kapur; J Gillespie; P J Guillou; G J Poston
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

Review 2.  Biology of pancreatic cancer.

Authors:  G J Poston; J Gillespie; P J Guillou
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 3.  Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.

Authors:  Jorge Berlanga-Acosta; Jorge Gavilondo-Cowley; Pedro López-Saura; Tania González-López; María D Castro-Santana; Ernesto López-Mola; Gerardo Guillén-Nieto; Luis Herrera-Martinez
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

4.  Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.

Authors:  P Watanapa; B Flaks; H Oztas; P H Deprez; J Calam; R C Williamson
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.